The participation of the following European Group for Blood and Marrow Transplantation (EBMT) centers is kindly acknowledged: CIC 160, Necker Hospital, Paris, France; CIC 726, University of Liege, Liege, Belgium; CIC 810, University of Freiburg, Freiburg, Germany; CIC 183, National Center of Bone Marrow Transplant, Tunis, Tunisia; CIC 202, University Hospital, Basel, Switzerland; CIC 751, St. Savas Oncology Hospital, Athens, Greece; CIC 428, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Gliwice, Poland; CIC 859, National Hospital of Hematological Diseases, Sofia, Bulgaria; CIC 323, University Hospital Virgen de la Arrixaca, Murcia, Spain; CIC 544, San Gerardo Hospital, Monza, Italy; CIC 208, University Hospital, Zurich, Switzerland; CIC 206, Rigshospitalet, Copenhagen, Denmark; CIC 682, University of Pecs, Pecs, Hungary; CIC 727, Lnico Hospital, Salamanca, Spain; CIC 259, University Hospital, Essen, Germany; CIC 728, Puerta de Hierro University Hospital, Madrid, Spain; CIC 240, Bologna University, Bologna, Italy; CIC 926, CHU Lapeyronie, Montpellier, France; CIC 283, University Hospital, Lund, Sweden; CIC 576, Carlos Haya Hospital, Malaga, Spain; CIC 546, University Medical Center Groningen, Groningen, the Netherlands; CIC 755, Schneider Children's Medical Center of Israel, Petach-Tikva, Israel; CIC 237, Radboud University-Nijmegen Medical Centre, Nijmegen, the Netherlands; CIC 749, Oldenburg Clinic, Oldenburg, Germany; CIC 661, Rennes University Medical Center, Rennes, France; CIC 640, University Medical Center, Ljubljana, Slovenia; CIC 996, Antwerp University Hospital, Antwerp, Belgium; CIC 244, West of Scotland Cancer Centre, Glasgow, Scotland, United Kingdom; CIC 625, Nurnberg Clinic, Nurnberg, Germany; CIC 295, Hannover Medical School, Hannover, Germany; CIC 710, RP Group, Royal Perth Hospital, Perth, Western Australia, Australia; CIC 754, Chaim Sheba Medical Center, Tel-Hashomer, Israel; CIC 266, University Hospital, Uppsala, Sweden; CIC 672, Hautepierre Hospital, Strasbourg, France; Paul Strauss Center, Strasbourg, France; CIC 241, Leon Berard Center, Lyon, France; CIC 169, Gazi Universitesi Tip Fakültesi Hastanesi, Ankara, Turkey; CIC 152, Augsburg Clinic, Augsburg, Germany; CIC 613, Germans Trias i Pujol University Hospital, Barcelona, Spain; CIC 659, CHU Morvan, Brest, France; CIC 246, Erasmus Medical Center-Daniel den Hoed Cancer Centre, Rotterdam, the Netherlands; CIC 257, St James Hospital, Trinity College, Dublin, Ireland; CIC 242, Marques de Valdecilla University Hospital, Santander, Spain; CIC 265, Maggiore di Milano Hospital, Milan, Italy; CIC 813, San Raffaele Scientific Institute, Milan, Italy; CIC 432, Henri-Mondor Hospital, Creteil, France; CIC 397, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia; CIC 232, La Sapienza University, Rome, Italy; CIC 227, Wien Medical University, Vienna, Austria; CIC 260, Santa Creu i Sant Pau Hospital, Barcelona, Spain; CIC 658, Riuniti di Bergamo Hospital, Bergamo, Italy; CIC 646, Heilig Hartziekenhuis, Roeselare, Belgium; CIC 217, San Martino Hospital, Genoa, Italy; CIC 261, University Hospital of Geneva, Geneva, Switzerland; CIC 409, Beilinson Hospital, Petach-Tikva, Israel; CIC 302, University Hospital Center Rebro, Zagreb, Croatia; CIC 800, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland; CIC 505, Pediatric Clinic/Outpatient Department, Department of Radiotherapy-Radiooncology, Munster, Germany.
Extreme heterogeneity of myeloablative total body irradiation techniques in clinical practice: A survey of the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation
Version of Record online: 7 MAY 2014
© 2014 American Cancer Society
Volume 120, Issue 17, pages 2760–2765, September 1, 2014
How to Cite
Giebel, S., Miszczyk, L., Slosarek, K., Moukhtari, L., Ciceri, F., Esteve, J., Gorin, N.-C., Labopin, M., Nagler, A., Schmid, C. and Mohty, M. (2014), Extreme heterogeneity of myeloablative total body irradiation techniques in clinical practice: A survey of the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Cancer, 120: 2760–2765. doi: 10.1002/cncr.28768
- Issue online: 20 AUG 2014
- Version of Record online: 7 MAY 2014
- Manuscript Accepted: 27 FEB 2014
- Manuscript Revised: 24 FEB 2014
- Manuscript Received: 2 JAN 2014
- 7Cyclophosphamide plus total body irradiation compared with busulfan plus cyclophosphamide as a conditioning regimen prior to hematopoietic stem cell transplantation in patients with leukemia: a systematic review and meta-analysis. Hematol Oncol Stem Cell Ther. 2011;4:17-29., , , .
- 15American College of Radiology; American Society for Radiation Oncology. American College of Radiology (ACR) and American Society for Radiation Oncology (ASTRO) practice guideline for the performance of total body irradiation (TBI). Am J Clin Oncol. 2013;36:97-101., , , et al;